ConductScience.org, home

Paper33009382

Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.

Deng H and 7 others. Nat Commun, 2020. Cited by 197 papers, by iCite.

Cite this record

ConductScience Library. Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death. Papers, record 33009382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33009382

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.
PubMed
Journal
Nat Commun
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
197
iCite
Relative citation ratio, by iCite
8.16
iCite
Revised in PubMed
2025-05-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deng HHongzhang
2Yang WWeijing
3Zhou ZZijian
4Tian RRui
5Lin LLisen
6Ma YYing
7Song JJibinhttps://orcid.org/0000-0003-4771-5006
8Chen XXiaoyuanhttps://orcid.org/0000-0002-9622-0870

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Extracellular SpaceMajor topic
Free Radical ScavengersMajor topic
Immunogenic Cell DeathMajor topic
Reactive Oxygen SpeciesMajor topic
Animals
Cell Line, Tumor
Dendritic Cells
HMGB1 Protein
Mice, Inbred BALB C
Particle Size
Polyethylene Glycols
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIA EB000073Intramural NIH HHSUnited StatesZIAEB000073PubMed

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in34210986Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.https://conductscience.org/library/papers/34210986

Source PubMed

Download CSV of comments and corrections

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.

PMIDTitleJournalYearIn PapersSource
42740837Research Progress of Multicomponent Co-Loaded Nanomedicine Delivery Systems for Tumor Immunotherapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42740837PubMed
42576968T-cell activity feedback-guided photothermal immunotherapy enabled by immune-responsive redox nanodots.Mater Today Bio2026https://conductscience.org/library/papers/42576968PubMed
42540416Hydrogel coatings for titanium implants: From smart stimuli-responsive strategies to multimodal bone regeneration.Bioact Mater2026https://conductscience.org/library/papers/42540416PubMed
42494420Erythrocyte-inspired biomaterials for cancer immunotherapy: Integration within the cancer-immunity cycle.Mater Today Bio2026https://conductscience.org/library/papers/42494420PubMed
42101631Redox-modulation of regulated cell death: implications for synergistic anticancer therapies.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42101631PubMed
42001355Plant-derived extracellular vesicles as a promising therapeutic and drug delivery strategy for tumor oxidative stress and inflammation.Discov Nano2026https://conductscience.org/library/papers/42001355PubMed
41914238Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol-Inspired Approach.Basic Clin Pharmacol Toxicol2026https://conductscience.org/library/papers/41914238PubMed
41821152Engineering MnPt Bimetallic Nanozymes for Cascade Enzymatic Therapy and Enhanced Radio-Immunotherapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41821152PubMed
41639675Cascade catalytic nanozyme platform for combined antibacterial, anti-inflammatory, and pro-healing therapy of infected diabetic wounds.J Nanobiotechnology2026https://conductscience.org/library/papers/41639675PubMed
41614403Mitochondria in T‑cell tumor immunity and tumor therapies targeting mitochondria (Review).Oncol Rep2026https://conductscience.org/library/papers/41614403PubMed
41365865Inhibiting the formation of neutrophil extracellular traps to prevent the recurrence of post-operative glioblastoma.Nat Commun2025https://conductscience.org/library/papers/41365865PubMed
41363830Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo-Immunometabolic Therapy.Wiley Interdiscip Rev Nanomed Nanobiotechnol2025https://conductscience.org/library/papers/41363830PubMed
41357129Scavenging of reactive oxygen and nitrogen species using nanoparticles and their applications in disease management.RSC Adv2025https://conductscience.org/library/papers/41357129PubMed
41246345Mitochondria-targeted strategies in tumor immunity.Front Immunol2025https://conductscience.org/library/papers/41246345PubMed
40696413Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.Exp Hematol Oncol2025https://conductscience.org/library/papers/40696413PubMed
40694096Dual-targeted protein-coated PLGA nanoparticles for pancreatic cancer therapy: a novel approach using esculetin and curcumin.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/40694096PubMed
40630838Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer.Biomater Res2024https://conductscience.org/library/papers/40630838PubMed
40585764Harnessing Biomarker Activatable Probes for Early Stratification and Timely Assessment of Therapeutic Efficacy in Cancer.Exploration (Beijing)2025https://conductscience.org/library/papers/40585764PubMed
40542357An oxygen-generating nanoplatform remodels the immunosuppressive tumor microenvironment via synergistic lactate depletion and sonodynamic therapy.J Nanobiotechnology2025https://conductscience.org/library/papers/40542357PubMed
40500674Optogenetic engineering for precision cancer immunotherapy.Trends Pharmacol Sci2025https://conductscience.org/library/papers/40500674PubMed

See all 86 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33009382

GET https://conductscience.org/api/papers/v1/33009382/cited_by?page=2